Additional 5 Years of AI Treatment Reduces Distant Recurrence Rates Among Postmenopausal Women Already Treated with at Least 5 Years of Endocrine Therapy By Ogkologos - August 25, 2025 516 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from a meta-analysis performed by the Early Breast Cancer Trialists’ Collaborative Group Source RELATED ARTICLESMORE FROM AUTHOR Advanced and metastatic prostate cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up PAXG Significantly Improves EFS Compared with mFOLFIRINOX in Patients with Resectable or Borderline Resectable Pancreatic Ductal Adenocarcinoma EMA Recommends Extension of Therapeutic Indications for Retifanlimab MOST POPULAR Soaring skin cancer cases hit a record high July 7, 2023 Cómo puede ayudar la terapia del piso pélvico a las personas... December 13, 2022 ESMO Targeted Anticancer Therapies Congress 2023 February 24, 2023 Opinion: ‘The idea that a tobacco company might profit off my... September 1, 2021 Load more HOT NEWS Science Surgery: ‘Can cancers develop in the heart?’ New Research in Treating Metastatic Breast Cancer, Preventing Breast Cancer, and... Promising pCR Rates with Neoadjuvant Durvalumab Plus Platinum-based Chemotherapy Combined with... FDA Approves First Adenoviral Vector-Based Gene Therapy for High-Risk Bacillus Calmette-Guérin...
